Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06293807 · ClinicalTrials.gov registry record · Early Phase 1

Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine

A Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
Early Phase 1
Development phase
72
Enrollment target

NCT06293807 is a Early Phase 1 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 72 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06293807, a Early Phase 1 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
Early Phase 1
Development phase
72 participants
Enrollment target

Study Summary

Immediate post-suturing administration of either one of two dental anesthetic solutions or a placebo prior to dismissal.

Interventions

  • OTHER Placebo
  • DRUG Xylocaine 2 % with 1:100,000 epinephrine
  • DRUG Bupivicaine 0.5% with 1:200,000 epinephrine

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2022-06-06
Est. Completion 2023-04-16
Phase Early Phase 1

What the Registry Record Tells You About NCT06293807

The ClinicalTrials.gov registry entry for NCT06293807 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT06293807 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06293807 about?

NCT06293807 is a clinical study titled "Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine". Immediate post-suturing administration of either one of two dental anesthetic solutions or a placebo prior to dismissal.

What is the current status of trial NCT06293807?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 72 participants. The study started on 2022-06-06. Estimated completion is 2023-04-16.

What interventions are being tested in trial NCT06293807?

The interventions under investigation include: Placebo (OTHER), Xylocaine 2 % with 1:100,000 epinephrine (DRUG), Bupivicaine 0.5% with 1:200,000 epinephrine (DRUG).

Who is sponsoring clinical trial NCT06293807?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.